Phase II Trial of Alternating mFOLFOX6 and FOLFIRI Regimens in the First-Line Treatment for Unresectable or Metastatic Colorectal Cancer (KSCC0701)

Oncology 2013;84:233–239 (DOI:10.1159/000346690)
Source: Karger Publishers - Category: Cancer & Oncology Source Type: research